12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several healthcare stocks experienced significant movements. OneMedNet (ONMD) saw a substantial increase of 172.1%, while Panbela Therapeutics (PBLA) faced a sharp decline of 62.5%. Other notable gainers include Jin Medical International (ZJYL), NovaBay Pharmaceuticals (NBY), Longeveron (LGVN), Palisade Bio (PALI), and Science 37 Hldgs (SNCE). Conversely, Aclarion (ACON), HOOKIPA Pharma (HOOK), Onconetix (ONCO), Elicio Therapeutics (ELTX), and Checkpoint Therapeutics (CKPT) were among the losers.
January 29, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Longeveron stock increased by 33.75% to $1.07, with a market cap of $26.8 million.
Longeveron's pre-market rise may indicate a positive short-term trend as investors respond to the price movement.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
NovaBay Pharmaceuticals shares rose by 35.54% to $0.22, with a market cap of $1.4 million.
The pre-market increase for NovaBay Pharmaceuticals may continue as the market opens, reflecting short-term investor optimism.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
OneMedNet's stock rose significantly by 172.1% to $1.39, with a market value of outstanding shares at $44.8 million.
The substantial pre-market increase in OneMedNet's stock price suggests a strong positive sentiment among investors, which could lead to further short-term gains as the market opens.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Palisade Bio shares rose by 24.3% to $0.65, with a market cap of $5.9 million.
The pre-market gain for Palisade Bio may lead to continued investor interest and potential short-term price increases.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Science 37 Hldgs stock increased by 20.88% to $5.73, with a market cap of $34.2 million.
Science 37 Hldgs' pre-market increase may suggest positive investor sentiment, potentially leading to further short-term gains.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Jin Medical International shares increased by 68.25% to $299.5, with a market cap of $2.3 billion.
Jin Medical International's significant pre-market rise could attract more investor attention, potentially leading to further short-term gains.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Panbela Therapeutics stock declined by 62.5% to $1.6 during Monday's pre-market session.
The significant pre-market decline in Panbela Therapeutics' stock price indicates negative investor sentiment, which could lead to further short-term downward pressure on the stock.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100